Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Kim, H. Florence
and
Fisch, Michael J.
2006.
Antidepressant use in ambulatory cancer patients.
Current Oncology Reports,
Vol. 8,
Issue. 4,
p.
275.
HAINER, VOJTECH
KABRNOVA, KAROLINA
ALDHOON, BASHAR
KUNESOVA, MARIE
and
WAGENKNECHT, MARTIN
2006.
Serotonin and Norepinephrine Reuptake Inhibition and Eating Behavior.
Annals of the New York Academy of Sciences,
Vol. 1083,
Issue. 1,
p.
252.
Montgomery, Stuart
2006.
Serotonin noradrenaline reuptake inhibitors: Logical evolution of antidepressant development.
International Journal of Psychiatry in Clinical Practice,
Vol. 10,
Issue. sup2,
p.
5.
Ramadan, Nabih M.
and
Buchanan, Thomas M.
2006.
New and future migraine therapy.
Pharmacology & Therapeutics,
Vol. 112,
Issue. 1,
p.
199.
King, Tamara
Rao, Srinivas
Vanderah, Todd
Chen, Qingmin
Vardanyan, Anna
and
Porreca, Frank
2006.
Differential Blockade of Nerve Injury–Induced Shift in Weight Bearing and Thermal and Tactile Hypersensitivity by Milnacipran.
The Journal of Pain,
Vol. 7,
Issue. 7,
p.
513.
McAllister-Williams, R Hamish
2006.
Duloxetine in the management of depression.
Future Neurology,
Vol. 1,
Issue. 6,
p.
713.
Thase, Michael E.
Clayton, Anita H.
Haight, Barbara R.
Thompson, April H.
Modell, Jack G.
and
Johnston, J. Andrew
2006.
A Double-blind Comparison Between Bupropion XL and Venlafaxine XR.
Journal of Clinical Psychopharmacology,
Vol. 26,
Issue. 5,
p.
482.
Baghai, Thomas C.
Volz, Hans-Peter
and
Möller, Hans-Jürgen
2006.
Drug treatment of depression in the 2000s: an overview of achievements in the last 10 years and future possibilities.
The World Journal of Biological Psychiatry,
Vol. 7,
Issue. 4,
p.
198.
Schwartz, Thomas L
and
Nihalani, Nikhil
2006.
Tiagabine in anxiety disorders.
Expert Opinion on Pharmacotherapy,
Vol. 7,
Issue. 14,
p.
1977.
Deecher, Darlene C.
Beyer, Chad E.
Johnston, Grace
Bray, Jenifer
Shah, S.
Abou-Gharbia, M.
and
Andree, Terrance H.
2006.
Desvenlafaxine Succinate: A New Serotonin and Norepinephrine Reuptake Inhibitor.
Journal of Pharmacology and Experimental Therapeutics,
Vol. 318,
Issue. 2,
p.
657.
Pakalapati, Ravi K
Bolisetty, Srinivas
Austin, Marie‐Paule
and
Oei, Julee
2006.
Neonatal seizures from in utero venlafaxine exposure.
Journal of Paediatrics and Child Health,
Vol. 42,
Issue. 11,
p.
737.
Wernicke, Joachim
Lled??, Alberto
Raskin, Joel
Kajdasz, Daniel K
and
Wang, Fujun
2007.
An Evaluation of the Cardiovascular Safety Profile of Duloxetine.
Drug Safety,
Vol. 30,
Issue. 5,
p.
437.
Higuchi, Teruhiko
and
Briley, Mike
2007.
Japanese experience with milnacipran, the first serotonin and norepinephrine reuptake inhibitor in Japan.
Neuropsychiatric Disease and Treatment,
Vol. 3,
Issue. 1,
p.
41.
Bradesi, Sylvie
and
Mayer, Emeran A
2007.
Novel therapeutic approaches in IBS.
Current Opinion in Pharmacology,
Vol. 7,
Issue. 6,
p.
598.
Stahl, Stephen M.
Ahmed, Saeeduddin
and
Haudiquet, Vincent
2007.
Analysis of the Rate of Improvement of Specific Psychic and Somatic Symptoms of General Anxiety Disorder During Long-Term Treatment with Venlafaxine ER.
CNS Spectrums,
Vol. 12,
Issue. 9,
p.
703.
Hartford, James
Kornstein, Susan
Liebowitz, Michael
Pigott, Teresa
Russell, James
Detke, Michael
Walker, Daniel
Ball, Susan
Dunayevich, Eduardo
Dinkel, Jeff
and
Erickson, Janelle
2007.
Duloxetine as an SNRI treatment for generalized anxiety disorder: results from a placebo and active-controlled trial.
International Clinical Psychopharmacology,
Vol. 22,
Issue. 3,
p.
167.
Kamath, Jayesh
DeMartinis, Nicholas
and
Handratta, Venkatesh
2007.
Efficacy and safety of desvenlafaxine succinate in the treatment of major depressive disorder.
Future Neurology,
Vol. 2,
Issue. 4,
p.
361.
Rosenzweig-Lipson, Sharon
Beyer, Chad E.
Hughes, Zoë A.
Khawaja, Xavier
Rajarao, Somana J.
Malberg, Jessica E.
Rahman, Zia
Ring, Robert H.
and
Schechter, Lee E.
2007.
Differentiating antidepressants of the future: Efficacy and safety.
Pharmacology & Therapeutics,
Vol. 113,
Issue. 1,
p.
134.
Millet, B.
2007.
Apport des ISRS et IRSNA dans l’anxiodépression.
L'Encéphale,
Vol. 33,
Issue. 4,
p.
699.
Millan, Mark J.
and
Dekeyne, Anne
2007.
Discriminative stimulus properties of the selective norepinephrine reuptake inhibitor, reboxetine, in rats: a characterization with α/β-adrenoceptor subtype selective ligands, antidepressants, and antagonists at neuropeptide receptors.
The International Journal of Neuropsychopharmacology,
Vol. 10,
Issue. 05,